5Dodd RY,Notari EP 4th,Stramer SL. Current prevalence and inci- deuce of infectious disease markers and estimated window-perlod risk in the American Red Cross blood donor population. Transfu- sion,2002,42 (8) :975- 979.
6Murokawa H, Yoshikawa A, Ohnuma H, et al. Japanese Red Cross NAT Screening Research Group. Epidemiology of blood donors in Japan ,positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang,2005,88 ( 1 ) :10-16.
7Shan H, Ren FR, Zhao HY, et al. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficleney virus wlth nucleic acid testing. Trans- fusion,2007, 47(11) :2011-2016.
8Vermeulen M, Lelie N, Sykes W, et al. Impact of individual-dona- tion nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus,and hepatitis C virus transmission by blood trans- fusion in South Africa. Transfusion,2009,49 (6) : 1115-1125.
9Yang MH ,Li L,Hung YS,et al. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion ,2010,50( 1 ) :65-74.
